Canada · Delayed Price · Currency is CAD Defence Therapeutics Statistics
Total Valuation
CSE:DTC has a market cap or net worth of CAD 26.53 million. The enterprise value is 26.36 million.
| Market Cap | 26.53M |
| Enterprise Value | 26.36M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DTC has 75.79 million shares outstanding. The number of shares has increased by 24.78% in one year.
| Current Share Class | 75.79M |
| Shares Outstanding | 75.79M |
| Shares Change (YoY) | +24.78% |
| Shares Change (QoQ) | +28.19% |
| Owned by Insiders (%) | 10.24% |
| Owned by Institutions (%) | n/a |
| Float | 68.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.56 |
| P/TBV Ratio | 7.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.49.
| Current Ratio | 3.42 |
| Quick Ratio | 3.37 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.00 |
Financial Efficiency
Return on equity (ROE) is -594.03% and return on invested capital (ROIC) is -112.55%.
| Return on Equity (ROE) | -594.03% |
| Return on Assets (ROA) | -75.53% |
| Return on Invested Capital (ROIC) | -112.55% |
| Return on Capital Employed (ROCE) | -94.32% |
| Weighted Average Cost of Capital (WACC) | 12.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -86,875 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.25% in the last 52 weeks. The beta is 1.51, so CSE:DTC's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -56.25% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 41.52 |
| Average Volume (20 Days) | 34,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.93M |
| Pretax Income | -6.78M |
| Net Income | -6.70M |
| EBITDA | -4.86M |
| EBIT | -4.93M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has 1.88 million in cash and 1.72 million in debt, with a net cash position of 161,322 or 0.00 per share.
| Cash & Cash Equivalents | 1.88M |
| Total Debt | 1.72M |
| Net Cash | 161,322 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 3.51M |
| Book Value Per Share | 0.05 |
| Working Capital | 3.10M |
Cash Flow
In the last 12 months, operating cash flow was -4.34 million and capital expenditures -419,634, giving a free cash flow of -4.76 million.
| Operating Cash Flow | -4.34M |
| Capital Expenditures | -419,634 |
| Depreciation & Amortization | 72,109 |
| Net Borrowing | 1.98M |
| Free Cash Flow | -4.76M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:DTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.78% |
| Shareholder Yield | -24.78% |
| Earnings Yield | -31.43% |
| FCF Yield | -17.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |